Recombinant Anti-B5 Env (aa 20-130) Neutralizing Antibody (V3S-0622-YC38) (CAT#: V3S-0622-YC38)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a human monoclonal antibody that reacts with B5 Env. The antibody displayed high binding affinities to B5 (Kd of 0.2 nM). The mAb inhibited the spread of vaccinia virus as well as variola virus in vitro, protected mice from subsequent intranasal challenge with virulent vaccinia virus, and provided significantly greater protection than that afforded by a previously isolated rat anti-B5 mAb or by vaccinia immune globulin. The mAb bound to a conformational epitope between amino acids 20 and 130 of B5.
Clonality Monoclonal
Host Species Human
Target Species Vaccinia Virus (VACV)
Epitope The epitope is located in the amino acids region 20-130.
Affinity 0.2 nM
Isotype IgG1

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and SEC-HPLC
Endotoxin <1 EU/mg
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within a week. For longer storage, aliquot and store at -20°C.

Applications

Application ELISA; WB; Neut; FuncS
Application Notes In vitro neutralizing activity
BS-C-1 cells were infected with about 50 pfu of VACV strain IHD-J. After 2 hours at 37°C, the monolayer was washed, and fresh medium containing indicated amounts of chimpanzee anti-B5 was added. After 48 hours, the monolayers were stained with crystal violet. For the smallpox assay (b), monolayers of BS-C-40 cells in six-well cell culture plates were infected with the Solaimen strain of variola virus at 50 pfu per well in RPMI medium containing 2% FBS. After 1 hour, the medium was aspirated; cells were washed twice and overlaid with RPMI medium containing 25, 2.5, or 0 ug of anti-B5 IgG. The plates were then incubated in a CO2 incubator for 4 days at 35.5°C. Cells were fixed and reacted with polyclonal rabbit anti-variola virus antibody. After incubation with goat anti-rabbit-HRP conjugate, comets were visualized by addition of TrueBlue peroxidase substrate.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target B5 Env
Alternative Name B5 envelope glycoprotein; B5; VACV; Vaccinia virus
Research Area Infectious Disease
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry